|
Principio, a developer of molecular imaging agents and therapeutic radiopharmaceuticals for the treatment of cancer, has obtained an exclusive license to several technologies developed at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore.
The American Society for Radiation Oncology (ASTRO) has announced the recipients of two grants funded by the Radiation Oncology Institute.
Whole-body MRI, because it is more likely to show abnormalities, can help detect chronic recurrent multifocal osteomyelitis, according to a study in the September issue of Radiology.
|
MRI-guided percutaneous core needle biopsy of lesions only visible on MR images is safe and provides a high diagnostic yield for the diagnosis of chronic recurrent multifocal osteomyelitis (CRMO) in children, according to a paper presented at the 2009 annual meeting of the Radiological Society of North America in Chicago earlier this month.
Seiji Ogawa, PhD, of the Hamano Life Science Research Foundation in Tokyo, who discovered that MRI could be used to measure oxygen flow in the brain in real time, making functional MRI (fMRI) possible, has been named as a possible winner of the 2009 Nobel Prize by researchers at Thomson Scientific, the science unit of Thomson Reuters.
Interventional radiologists are establishing how to use stem cells to create new or more blood vessels to treat peripheral arterial disease (PAD) in individuals with extensively narrowed or clogged arteries. Recent successful techniques use imaging to view and locate transplanted stem cells, and to confirm that they remain alive in the body once injected, according to a study presented at the Society of Interventional Radiology (SIR) annual conference this week in San Diego.
|